Remove 2012 Remove Document Remove Equity Remove Startup
article thumbnail

The Truth About Convertible Debt at Startups and The Hidden Terms You Didn’t Understand

Both Sides of the Table

This time by the efforts of Adeo Ressi to introduce a new kind of structure called “ convertible equity.” My initial reaction to Adeo when we spoke was that while it may have solved some issues (debt versus equity) it didn’t solve the ones that I’ve been warning entrepreneurs about most loudly.

Startup 354
article thumbnail

Accounting and Taxation for Startups

SoCal Tech Calendar

Thursday, May 10, 2012 -- Accounting and Taxation for Startups. We will go back to basics and review the balance sheet, income statement and statement of equity accounts and talk about what pitfalls you need to watch for. See [link] (more)

OCTANE 100
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Add Startups to Balance Your Portfolio, If You Dare

Startup Professionals Musings

Reuters TV Interview by Rhonda Schaffler Investing in entrepreneurs and startups is a fun but different world from investing in conventional stocks, bonds, and commodities. First of all, it’s more of an investment in people than in a business, since the startup is usually an idea barely half-baked when they need your money.

Startup 91
article thumbnail

10 Keys To Giving The Right Entrepreneur Your Money

Startup Professionals Musings

Investing in entrepreneurs and startups is a fun but different world from investing in conventional stocks, bonds, and commodities. First of all, it’s more of an investment in people than in a business, since the startup is usually an idea barely half-baked when they need your money. Start in a business domain you know well.

article thumbnail

Audentes Prices $75M IPO As Gene Therapy Eyes First U.S. Approval

Xconomy

Gene therapy’s multi-decade roller-coaster ride has been well documented, in Xconomy and elsewhere. But even with many recent ups and downs and questions regarding how broadly gene therapies will be used, how much they’ll cost, and how long they’ll last, the field is as close as its ever been to impacting healthcare.

Pricing 40